Case number 2016-1596
Amarin Pharma, Inc. v. Watson Laboratories, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 8, 2016 | 26 | ORDER granting motion to terminate appeal [25] filed by Appellant Watson Laboratories, Inc.; issuing mandate. Service as of this date by Clerk of Court. [341955] [SJ] [Entered: 06/08/2016 03:40 PM] (2) |
| Jun 7, 2016 | 25 | MOTION of Appellant Watson Laboratories, Inc. to terminate appeal through Voluntary Dismissal. [Consent: unopposed]. Service: 06/07/2016 by email. [341692] [Thomas Meloro] [Entered: 06/07/2016 05:37 PM] (4) |
| May 26, 2016 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file appellees' principal brief [23] filed by Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. Appellees' brief is due 06/30/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [338627] [AT] [Entered: 05/26/2016 09:27 AM] (0) |
| May 24, 2016 | 23 | MOTION of Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. to extend the time to 06/30/2016 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 06/06/2016 [Consent: unopposed]. Service: 05/24/2016 by email. [338219] [Michael Kennedy] [Entered: 05/24/2016 11:59 PM] (6) |
| May 4, 2016 | 22 | 6 paper copies of the Opening Brief [21] received from Appellant Watson Laboratories, Inc. [332830] [JCP] [Entered: 05/06/2016 11:14 AM] (0) |
| May 2, 2016 | 20 | TENDERED from Appellant Watson Laboratories, Inc.. Title: OPENING BRIEF. Service: 05/02/2016 by email. [331403] [Thomas Meloro] [Entered: 05/02/2016 06:46 PM] (45) |
| May 2, 2016 | 21 | BRIEF FILED for Appellant Watson Laboratories, Inc. [20]. Number of Pages: 23. Service: 05/02/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/09/2016. Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. brief is due 06/16/2016. [331512] [AT] [Entered: 05/03/2016 09:56 AM] (45) |
| Apr 11, 2016 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [18] filed by Appellant Watson Laboratories, Inc. Brief due 05/02/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [325272] [AT] [Entered: 04/11/2016 08:04 AM] (0) |
| Apr 8, 2016 | 18 | MOTION of Appellant Watson Laboratories, Inc. to extend the time to 05/02/2016 to file the appellant/petitioner's principal brief. Response/Opposition is due 04/21/2016 [Consent: unopposed]. Service: 04/08/2016 by email. [325246] [Michael Johnson] [Entered: 04/08/2016 04:39 PM] (6) |
| Apr 4, 2016 | 15 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Watson Laboratories, Inc.. Service: 04/04/2016 by email. [323764] [Thomas Meloro] [Entered: 04/04/2016 04:12 PM] (3) |
| Apr 4, 2016 | 16 | Entry of appearance for Alexandra F. Awai as of counsel for Appellant Watson Laboratories, Inc.. Service: 04/04/2016 by email. [323767] [Alexandra Awai] [Entered: 04/04/2016 04:19 PM] (2) |
| Apr 4, 2016 | 17 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 04/04/2016 by email. [323816] [Benjamin Block] [Entered: 04/04/2016 06:34 PM] (3) |
| Mar 4, 2016 | 12 | NOTICE OF DEFICIENCY: The docketing statement Document No. [8] and certificate of interest Document No. [7] filed by Appellant Watson Laboratories, Inc. in 16-1596 are incomplete and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiencies. CLERK'S NOTE: Statement 2 on the COI, and Statement 1 on page 2 of the docketing statement are blank. All statements on these forms must contain a response. If a statement does not apply, you may respond with "none" or "not applicable". At the discretion of the court, the corrected documents may be accepted for filing if received before midnight (EST) on the date of this notice. [315846] [AT] [Entered: 03/04/2016 08:25 AM] (0) |
| Mar 4, 2016 | 13 | Corrected Certificate of Interest for the Appellant Watson Laboratories, Inc.. Service: 03/04/2016 by email. [315957] [Thomas Meloro] [Entered: 03/04/2016 12:22 PM] (2) |
| Mar 4, 2016 | 14 | Corrected Docketing Statement for the Appellant Watson Laboratories, Inc.. Service: 03/04/2016 by email. [315959] [Thomas Meloro] [Entered: 03/04/2016 12:25 PM] (4) |
| Mar 3, 2016 | 10 | Certificate of Interest for the Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 03/03/2016 by email. [315798] [Michael Kennedy] [Entered: 03/03/2016 04:35 PM] (3) |
| Mar 3, 2016 | 11 | Docketing Statement for the Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 03/03/2016 by email. [315799] [Michael Kennedy] [Entered: 03/03/2016 04:37 PM] (3) |
| Mar 2, 2016 | 5 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellant Watson Laboratories, Inc.. Service: 03/02/2016 by email. [315519] [Thomas Meloro] [Entered: 03/02/2016 06:01 PM] (2) |
| Mar 2, 2016 | 6 | Entry of appearance for Michael W. Johnson as of counsel for Appellant Watson Laboratories, Inc.. Service: 03/02/2016 by email. [315520] [Michael Johnson] [Entered: 03/02/2016 06:04 PM] (2) |
| Mar 2, 2016 | 7 | Certificate of Interest for the Appellant Watson Laboratories, Inc.. Service: 03/02/2016 by email. [315521] [Thomas Meloro] [Entered: 03/02/2016 06:07 PM] (2) |
| Mar 2, 2016 | 8 | Docketing Statement for the Appellant Watson Laboratories, Inc.. Service: 03/02/2016 by email. [315522] [Thomas Meloro] [Entered: 03/02/2016 06:08 PM] (4) |
| Mar 2, 2016 | 9 | Transcript Purchase Order Form for the Appellant Watson Laboratories, Inc. indicating that a transcript is not needed for the appeal. Service: 03/02/2016 by email. [315523] [Thomas Meloro] [Entered: 03/02/2016 06:10 PM] (2) |
| Feb 26, 2016 | 2 | Entry of appearance for Christopher N. Sipes as principal counsel for Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 02/26/2016 by email. [314316] [Christopher Sipes] [Entered: 02/26/2016 06:29 PM] (2) |
| Feb 26, 2016 | 3 | Entry of appearance for Michael N. Kennedy as of counsel for Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 02/26/2016 by email. [314317] [Michael Kennedy] [Entered: 02/26/2016 06:38 PM] (2) |
| Feb 26, 2016 | 4 | Entry of appearance for Benjamin Block as of counsel for Appellees Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.. Service: 02/26/2016 by email. [314318] [Benjamin Block] [Entered: 02/26/2016 06:45 PM] (2) |
| Feb 18, 2016 | 1 | Appeal docketed. Received: 02/17/2016. [312004]Entry of Appearance due 03/03/2016. Certificate of Interest is due on 03/03/2016. Docketing Statement due 03/03/2016. Appellant's brief is due 04/18/2016. [AT] [Entered: 02/18/2016 11:46 AM] (25) |
